- Home
- FTRE vs PFLT Comparison
FTRE vs PFLT Comparison
Compare FTRE & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- PFLT
- Stock Information
- Founded
- FTRE 1996
- PFLT 2010
- Country
- FTRE United States
- PFLT United States
- Employees
- FTRE N/A
- PFLT N/A
- Industry
- FTRE Medical Specialities
- PFLT Finance: Consumer Services
- Sector
- FTRE Health Care
- PFLT Finance
- Exchange
- FTRE Nasdaq
- PFLT Nasdaq
- Market Cap
- FTRE 864.4M
- PFLT 1.0B
- IPO Year
- FTRE N/A
- PFLT N/A
- Fundamental
- Price
- FTRE $10.35
- PFLT $9.34
- Analyst Decision
- FTRE Hold
- PFLT Buy
- Analyst Count
- FTRE 9
- PFLT 6
- Target Price
- FTRE $13.06
- PFLT $10.75
- AVG Volume (30 Days)
- FTRE 1.1M
- PFLT 1.5M
- Earning Date
- FTRE 11-05-2025
- PFLT 11-24-2025
- Dividend Yield
- FTRE N/A
- PFLT 13.56%
- EPS Growth
- FTRE N/A
- PFLT N/A
- EPS
- FTRE N/A
- PFLT 0.81
- Revenue
- FTRE $2,733,500,000.00
- PFLT $247,973,000.00
- Revenue This Year
- FTRE N/A
- PFLT $42.15
- Revenue Next Year
- FTRE N/A
- PFLT $11.75
- P/E Ratio
- FTRE N/A
- PFLT $11.39
- Revenue Growth
- FTRE N/A
- PFLT 48.88
- 52 Week Low
- FTRE $3.97
- PFLT $8.40
- 52 Week High
- FTRE $25.28
- PFLT $11.56
- Technical
- Relative Strength Index (RSI)
- FTRE 55.61
- PFLT 59.20
- Support Level
- FTRE $10.11
- PFLT $8.40
- Resistance Level
- FTRE $11.55
- PFLT $8.90
- Average True Range (ATR)
- FTRE 0.64
- PFLT 0.18
- MACD
- FTRE 0.04
- PFLT 0.12
- Stochastic Oscillator
- FTRE 55.47
- PFLT 97.95
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.